Viva Biotech Holdings (VBIZF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 391.01 Million CNY | 59.43% |
| 2022 | 372.66 Million CNY | -38.78% |
| 2021 | 683.96 Million CNY | 263.9% |
| 2020 | -223.89 Million CNY | -513.78% |
| 2019 | 317.23 Million CNY | 185.62% |
| 2018 | 31.42 Million CNY | -46.06% |
| 2017 | 58.26 Million CNY | 80.9% |
| 2016 | 32.4 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 14.82 Million USD | 0.0% |
| 2024 Q1 | 14.92 Million USD | -37.74% |
| 2023 FY | - CNY | 59.43% |
| 2023 Q1 | 16.6 Million USD | -56.1% |
| 2023 Q2 | 33.27 Million USD | 100.35% |
| 2023 Q3 | 11.15 Million USD | -66.48% |
| 2023 Q4 | 23.96 Million USD | 114.83% |
| 2022 FY | - CNY | -38.78% |
| 2022 Q4 | 37.83 Million USD | 113.57% |
| 2022 Q3 | 17.71 Million USD | -38.76% |
| 2022 Q2 | 28.92 Million USD | 0.0% |
| 2021 Q4 | 30.94 Million USD | 0.0% |
| 2021 FY | - CNY | 263.9% |
| 2021 Q2 | 29.1 Million USD | 0.0% |
| 2020 Q2 | 8.46 Million USD | 0.0% |
| 2020 Q4 | 17.96 Million USD | 0.0% |
| 2020 FY | - CNY | -513.78% |
| 2019 Q2 | 6.51 Million USD | 0.0% |
| 2019 Q4 | 6.28 Million USD | 0.0% |
| 2019 FY | - CNY | 185.62% |
| 2018 FY | - CNY | -46.06% |
| 2017 FY | - CNY | 80.9% |
| 2016 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | -3.06 Million USD | 12865.588% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 11123.745% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | 17215.95% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 2351.077% |
| GB Sciences, Inc. | -1.41 Million USD | 27638.287% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | -103111.876% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | 3197515.978% |
| Skye Bioscience, Inc. | -13.54 Million USD | 2986.219% |
| Zenith Capital Corp. | -8.6 Million USD | 4643.481% |
| Agentix Corp. | -1.37 Million USD | 28604.486% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 10166.421% |
| Biomind Labs Inc. | -1.03 Million USD | 37895.407% |
| ContraFect Corporation | -64.99 Million USD | 701.566% |
| CSL Limited | 4.78 Billion USD | 91.835% |
| CytoDyn Inc. | -18.02 Million USD | 2268.795% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | -5815069.542% |
| Neon Bloom, Inc. | -632.4 Thousand USD | 61929.268% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 806.576% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | 106578.66% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 25555.698% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | 41832.474% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | -315.802% |
| SQZ Biotechnologies Company | -64.14 Million USD | 709.613% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | 26388.076% |
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 650.442% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 14886.148% |
| Mesoblast Limited | -62.38 Million USD | 726.725% |
| Marizyme, Inc. | -34.28 Million USD | 1240.593% |
| Genus plc | 73.7 Million USD | -430.545% |
| Pharming Group N.V. | 9.87 Million USD | -3858.813% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 4557.501% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 27993.406% |
| IMV Inc. | -35.52 Million USD | 1200.717% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | 16926.26% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | 75578.239% |
| ONE Bio Corp. | 13.61 Million USD | -2772.333% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 910.774% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | -10846.585% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 13618.946% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 5560.089% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 1564148.0% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 2563.885% |
| Alpha Cognition Inc. | -9.7 Million USD | 4128.725% |
| Enzolytics Inc. | -2.12 Million USD | 18526.327% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -216.02 Million USD | 281.005% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | -32029.17% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | -4316.318% |
| Genscript Biotech Corporation | -248.71 Million USD | 257.21% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 6695.008% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | 163600.732% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | 16082.76% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | 222235.164% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | 20455.55% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 6014.104% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 8738.868% |
| Adynxx, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Accustem Sciences Inc. | -3.74 Million USD | 10536.953% |
| Helix BioMedix, Inc. | -1.04 Million USD | 37470.498% |
| EV Biologics, Inc. | -1.26 Million USD | 30958.032% |
| Q BioMed Inc. | -617.62 Thousand USD | 63408.658% |
| Capstone Therapeutics Corp. | -1.74 Million USD | 22443.556% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 1086.486% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| BioStem Technologies, Inc. | -7.55 Million USD | 5276.468% |
| Curative Biotechnology, Inc. | -2.5 Million USD | 15728.215% |
| HST Global, Inc. | -5303.00 USD | 7373511.277% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | 19108.848% |
| Halberd Corporation | -74.27 Thousand USD | 526509.887% |
| Resverlogix Corp. | -11.74 Million USD | 3430.029% |
| Cell Source, Inc. | -4.27 Million USD | 9251.776% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | 26186.492% |
| GeneThera, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | -6.11 Million USD | 6496.775% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | 2244586.539% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | -1.03 Million USD | 37886.348% |
| Kadimastem Ltd | -2.62 Million USD | 14999.209% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | 103100.896% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | -181.08 Thousand USD | 216023.75% |
| LadRx Corporation | 412.28 Thousand USD | -94740.68% |
| Regen BioPharma, Inc. | 1.46 Million USD | -26572.833% |
| Affymax, Inc. | -14.29 Million USD | 2835.306% |
| Itoco Inc. | -1.86 Million USD | 21020.976% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 35136.918% |
| Mobile Lads Corp. | -2.24 Million USD | 17546.866% |
| International Stem Cell Corporation | 202 Thousand USD | -193470.297% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bioxytran, Inc. | -3.82 Million USD | 10335.522% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | 494870.274% |
| Qrons Inc. | -40.08 Thousand USD | 975654.502% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | 80608.485% |
| SYBLEU INC | -141.57 Thousand USD | 276294.983% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | -74034.914% |
| Rebus Holdings, Inc. | -951 Thousand USD | 41215.878% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | 36918.109% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | 742903.951% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | 15982.323% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 1190.111% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | -45 Thousand USD | 869015.556% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 14380.935% |
| Neutra Corp. | -181.24 Thousand USD | 215834.329% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 2039.64% |
| PureTech Health plc | -11.62 Million USD | 3462.966% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 2039.773% |
| IXICO plc | -707 Thousand USD | 55405.799% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 5187.99% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 908.778% |
| CSL Limited | 4.73 Billion USD | 91.739% |
| Cellectis S.A. | -92.63 Million USD | 522.095% |